Gavi HPV Programs: Application to Implementation (Q26783803)

1

0 references

Linda Eckert

2

0 references

Paul Bloem

3

0 references

Tania Cernuschi

Creative Commons Attribution 4.0 International

4

0 references

language of work or name

English

0 references

publication date

2015

0 references

1 reference

3

0 references

issue

2

0 references

page(s)

408-19

0 references

copyright license

start time

20 May 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Effective nonvaccine interventions to be considered alongside human papilloma virus vaccine delivery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Human papillomavirus vaccine introduction--the first five years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Immunizing school-age children and adolescents: experience from low- and middle-income countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Chapter 1: HPV in the etiology of human cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Human papillomavirus and cervical cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FVACCINES3020408

Comprehensive control of human papillomavirus infections and related diseases.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FVACCINES3020408

Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FVACCINES3020408

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4494350

Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 –- conclusions and recommendations

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26343194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gardasil: from bench, to bedside, to blunder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26343194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human papillomavirus vaccines. WHO position paper

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26343194